The value of HPV vaccination

Nature Medicine

Volumn 18, Issue 1, 2012, Pages 28-29

  Kim, Jane ^a   Smith McCune, Karen K ^b   Melief, Cornells J M ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PAPILLOMAVIRUS VACCINE, L1 TYPE 16, 18; WART VIRUS VACCINE;

ARTICLE; CLINICAL TRIAL (TOPIC); FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

CLINICAL TRIALS AS TOPIC; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 84858300274     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0112-28     Document Type: Article

References (14)

1. Lehtinen, M. et al. Lancet Oncol. published online, doi:10.1016/S1470-2045(11)70286-8 (8 November 2011).
2. Wheeler, C. et al. Lancet Oncol. published online, doi:10.1016/S1470-2045(11)70287-X (8 November 2011).
3. Brown, D.R. et al. J. Infect. Dis. 199, 926-935 (2009).
4. Hoy, T., Singhal, P.K., Willey, V.J. & Insinga, R.P. Curr. Med. Res. Opin. 25, 2343-2351 (2009).
5. Goldie, S.J. et al. Vaccine 26, 4080-4093 (2008).
6. Muñoz, N. et al. J. Natl. Cancer Inst. 102, 325-339 (2010).
7. Lowy, D.R., Solomon, D., Hildesheim, A., Schiller, J.T. & Schiffman, M. Cancer 113, Suppl. 7, 1980-1993 (2008).
8. Brotherton, J.M. et al. Lancet 377, 2085-2092 (2011).
9. Gee, J. et al. Vaccine 29, 8279-8284 (2011).
10. Einstein, M.H. et al. Hum. Vaccin. 7, 1359-1373 (2011).
11. Romanowski, B. et al. Lancet 374, 1975-1985 (2009).
12. Kjær, S.K., Frederiksen, K., Munk, C. & Iftner, T. J. Natl. Cancer Inst. 102, 1478-1488 (2010).
13. Barr, E. et al. Am. J. Obstet. Gynecol. 198, 261.e1-261.e11 (2008).
14. Centers for Disease Control and Prevention. MMWR Morb. Mortal. Wkly. Rep. 59, 626-629 (2010).